| P50 | author | Thomas H. Gillingwater | Q37373419 |
| P2093 | author name string | Gillian Hunter | |
| | Sarah L Roche | |
| | Arwin Aghamaleky Sarvestany | |
| | Rebecca C Symes | |
| P2860 | cites work | Spinal muscular atrophy astrocytes exhibit abnormal calcium regulation and reduced growth factor production | Q37614887 |
| | Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond | Q37642283 |
| | Glial cells in amyotrophic lateral sclerosis | Q37902077 |
| | Spinal muscular atrophy: going beyond the motor neuron | Q38066335 |
| | Unwrapping the genes of myelin | Q38211942 |
| | A mouse model for spinal muscular atrophy | Q38316939 |
| | Protein zero gene expression is regulated by the glial transcription factor Sox10 | Q39452670 |
| | Defective Ca2+ channel clustering in axon terminals disturbs excitability in motoneurons in spinal muscular atrophy | Q39751507 |
| | Direct regulation of myelin protein zero expression by the Egr2 transactivator | Q40337072 |
| | SCIP: a glial POU domain gene regulated by cyclic AMP. | Q41836479 |
| | Arrest of myelination and reduced axon growth when Schwann cells lack mTOR. | Q41880723 |
| | P(0) glycoprotein overexpression causes congenital hypomyelination of peripheral nerves | Q42919149 |
| | The dorsolateral corticospinal tract in mice: an alternative route for corticospinal input to caudal segments following dorsal column lesions | Q43533356 |
| | The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy | Q43569750 |
| | Pre-symptomatic development of lower motor neuron connectivity in a mouse model of severe spinal muscular atrophy | Q43932877 |
| | A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice | Q46070173 |
| | Cytoarchitecture of the Spinal Cord of the Postnatal (P4) Mouse | Q46563242 |
| | Myelination in mouse dorsal root ganglion/Schwann cell cocultures | Q46800185 |
| | Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy | Q46861362 |
| | Mouse schwann cells need both NRG1 and cyclic AMP to myelinate | Q47169288 |
| | Synaptic defects in type I spinal muscular atrophy in human development | Q47322638 |
| | Peripheral nerve abnormalities in pediatric patients with spinal muscular atrophy | Q48562187 |
| | Isolation, purification and expansion of myelination-competent, neonatal mouse Schwann cells. | Q50929339 |
| | Laminin induced local axonal translation of β-actin mRNA is impaired in SMN-deficient motoneurons | Q53151357 |
| | Alternative splicing events are a late feature of pathology in a mouse model of spinal muscular atrophy | Q21144988 |
| | Wrapping it up: the cell biology of myelination | Q22337362 |
| | The POU factor Oct-6 and Schwann cell differentiation | Q24319829 |
| | Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease | Q24621854 |
| | SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy | Q28271235 |
| | Neurofascins are required to establish axonal domains for saltatory conduction | Q28512452 |
| | Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons | Q28576647 |
| | Identification and characterization of a spinal muscular atrophy-determining gene | Q29547495 |
| | Descending pathways to the spinal cord, III: Sites of origin of the corticospinal tract | Q29998971 |
| | Analysis of congenital hypomyelinating Egr2Lo/Lo nerves identifies Sox2 as an inhibitor of Schwann cell differentiation and myelination | Q30856297 |
| | Spinal muscular atrophy. | Q33345749 |
| | The molecular machinery of myelin gene transcription in Schwann cells | Q34092185 |
| | Prospects for the gene therapy of spinal muscular atrophy | Q34165703 |
| | Protein composition of myelin of the peripheral nervous system | Q34216787 |
| | The origin and development of glial cells in peripheral nerves | Q34447586 |
| | Morphological characteristics of motor neurons do not determine their relative susceptibility to degeneration in a mouse model of severe spinal muscular atrophy | Q34534222 |
| | Motor nerve conduction velocity in spinal muscular atrophy of childhood | Q34989452 |
| | Muscles in a mouse model of spinal muscular atrophy show profound defects in neuromuscular development even in the absence of failure in neuromuscular transmission or loss of motor neurons | Q35126847 |
| | Disease mechanisms in inherited neuropathies | Q35209953 |
| | Dysfunction of axonal membrane conductances in adolescents and young adults with spinal muscular atrophy | Q35540059 |
| | Severe neuromuscular denervation of clinically relevant muscles in a mouse model of spinal muscular atrophy | Q35605208 |
| | Schwann cell myelination requires integration of laminin activities | Q36407316 |
| | Interactions of Sox10 and Egr2 in myelin gene regulation | Q37020396 |
| | Regulation of Schwann cell function by the extracellular matrix. | Q37273622 |
| | Molecular domains of myelinated axons in the peripheral nervous system | Q37273627 |
| | Cell death in the Schwann cell lineage and its regulation by neuregulin | Q37390514 |
| | Notch controls embryonic Schwann cell differentiation, postnatal myelination and adult plasticity. | Q37436957 |
| P433 | issue | 9 | |
| P921 | main subject | Schwann cell | Q465621 |
| | spinal muscular atrophy | Q580290 |
| P304 | page(s) | 2235-2250 | |
| P577 | publication date | 2013-12-02 | |
| P1433 | published in | Human Molecular Genetics | Q2720965 |
| P1476 | title | SMN-dependent intrinsic defects in Schwann cells in mouse models of spinal muscular atrophy | |
| P478 | volume | 23 | |